Course faculty for the 2011 Surgical Invention Convention include practicing urologic clinicians and surgeons, engineering and business experts and legal experts in patent and regulatory processes.

 

Course Directors

L. Franklin Bost, MBA, IDSA

Prof. Bost is Professor and Director of Design Instruction at the Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University. He teaches sophomore design and the capstone senior design classes. He is also President and Chief Executive Officer of SpherIngenics, Inc. an early-stage biotechnology company specializing in stem cell delivery technologies.

He has extensive business experience in strategic planning, new product development, senior management and leadership with companies in medical, consumer and industrial markets. He was previously president of Porex Surgical Inc. a biomaterials company, with implantable products for craniofacial reconstruction, oculoplastics, otolaryngologist, oral maxillofacial and neurosurgeons. He has held senior management positions with Porex Corporation, a medical, consumer and industrial products company. Early in his career, he worked for American Hospital Supply in product development and with Becton Dickinson in their hemodialysis business.

Prof. Bost holds an MBA from the University of North Carolina and a Bachelor of Product Design degree from North Carolina State University. He is a member of the Industrial Designers Society of America (IDSA), Society of Biomaterials, Biomedical Engineering Society, Regulatory Affairs Professionals Society and the American Association for the Advancement of Science. Mr. Bost serviced on AdvaMed’s Technology and Regulatory committee from 1994 to 2006.

 

Anthony A. Malizia, Jr., MD

Dr. Malizia is a nationally-known urologic surgeon with a primary interest in the diagnosis and treatment of prostate cancer. He has treated patients from 31 states and four countries. After graduating from Tulane University, he received his MD degree from the Medical College of Georgia, and completed an internship in general surgery and a urology residency at the Mayo Clinic in Rochester, Minnesota. He was awarded an American Medical Association Research Fellowship.

He was an instructor at Mayo Medical School and served on the clinical faculty of Emory University for many years, where he was named Teacher of the Year for four consecutive years. He held the position as an affiliate scientist at Yerkes Primate Center for 10 years. Dr. Malizia also served on the FDA Devices Panel in Washington, DC and has numerous medical publications and patents. He is active in many professional organizations and and is a Fellow of the American College of Surgeons and Diplomat of the American Board of Urology. Part of his mission is to teach medical professionals to understand how to care for patients, not just treat them.

 

Keynote Speakers

 

Edward M. Copeland III, MD, FACS

Dr. Edward M. Copeland III is a Distinguished Professor of Surgery at the University of Florida College of Medicine. He received his BA degree from Duke University, his MD Degree from Cornell University Medical College and completed his residency in General Surgery at the Hospital of the University of Pennsylvania. After military service as a Major in Viet Nam where he received the Bronze Star, he completed an Advanced Senior Fellowship in Cancer Surgery at the M.D. Anderson Hospital and Tumor Institute. He began his career at the University of Texas Medical School at Houston and at the M.D. Anderson Hospital where he progressed to the rank of Professor of Surgery before leaving in 1982 to assume the Chairmanship of the Department of Surgery at the University of Florida thru 2003. During this time, he also served as Interim Dean of the Medical School and the first Director of the University of Florida-Shands Cancer Center. He was elected to Distinguished Professor in 2004 and received the Life Time Achievement Award in 2008. He is currently a member of the Board of Directors of the Highlands-Cashiers Hospital and Wild Cat Cliffs Country Club, both in Highlands, NC.

Dr. Copeland is the recipient of the Distinguished Alumnus Award from the MD Anderson Hospital, the Heritage Award from the Society of Surgical Oncology and Honorary Fellowships of the Royal College of Surgeons in Ireland, the Society of Black Academic Surgeons, the Southeastern Surgical Society and the Texas Surgical Society. He is past president of the Association for Academic Surgery, Halsted Society, Society of Surgical Chairman, Society of Surgical Oncology, Southern Surgical Association, Southeastern Surgical Congress and the American College of Surgeons. He is past Chairman of the American Board of Surgery, the Board of Governors of the American College of Surgeons and the Board of Regents of the American College of Surgeons. His bibliography includes 462 journal articles and book chapters and 87 published abstracts and editorials. He is the editor or co-editor of 23 books and either is or has been a member of 17 editorial boards to include the Associate Editor of the Annals of Surgical Oncology, Editor of the Year Book of Surgery and Co-editor with Dr. Kirby I. Bland of the tome, Breast Cancer: Comprehensive Management of Benign and Malignant Disorders now in its 4th Edition. His research interests are in surgical nutrition, metabolism and tumor biology.

 

Howard M. Jenkins

Howard M. Jenkins is Chairman of the Executive Committee of Publix Super Markets, Inc., and Chairman of the Board of Directors of Malizia Clinic. 

Mr. Jenkins began his career with Publix in 1966 as front service clerk, learning the entire retail operation of the company by time spent as a stock clerk, meat cutter, deli clerk, produce clerk and on to store management. After working as Equipment Buyer, Mr. Jenkins assumed the position of Vice President of Research and Development where he developed Publix’s Electronic Funds Transfer System, known as PRESTO! In 1986, Mr. Jenkins was named to the position of Chairman of the Executive Committee as he began to actively participate in the direction of the entire operation of Publix Super Markets. In January, 1990, Mr. Jenkins was named Chairman and Chief Executive Officer. In May, 2001, Mr. Jenkins relinquished the title of CEO and retained the title of Chairman of the Board until March 30, 2008 when he became Chairman of the Executive Committee. In the 1980’s Mr. Jenkins served on the Board of Directors for United Way of Central Florida.  He was also involved in the United Way of Central Florida’s Blue Ribbon Committee by serving on the Board of Success by Six. Mr. Jenkins served on the Board of Trustees for the Take Stock in Children program in Florida.  He has also served on the Board of Trustees for Emory University and Food Marketing Institute, the food industry’s premier trade organization.  He was honored by the Rotary Club when they presented him with the Paul Harris Fellowship award.

 
Faculty

 

 Dr. Barbara D. Boyan, Ph.D.

Dr. Boyan is the Price Gilbert, Jr. Chair in Tissue Engineering and professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. She is a Georgia Research Alliance (GRA) Eminent Scholar and Associate Dean for Research in the College of Engineering. Dr. Boyan is also director of the Children’s Healthcare of Atlanta’s Laboratory for Craniofacial Plastic Surgery Research. She is a past chair of the Orthopaedic Device Panel of the US Food & Drug Administration and a past president of the American Association of Dental Research. She is a Fellow in AAAS and in AIMBE. In 1993, she co-founded OsteoBiologics, Inc. (San Antonio, Texas), which was acquired by Smith & Nephew in 2007. OBI’s first generation of products is now approved for use clinically both in the US and Europe.

Dr. Boyan is also founder of Biomedical Development Corporation in San Antonio, as well as Orthonics, Inc. and SpherIngenics, Inc. in Atlanta. She sits on the Board of Directors of Arthrocare, Inc. (Austin, TX) and Carticept Medical, Inc. (Alpharetta, GA). The author of more than 360 peer-reviewed papers, reviews, and book chapters, Dr. Boyan holds eight U.S. and international patents.

 

Brittanny Boyer

Brittanny Boyer graduated from Georgia Institute of Technology in December 2010 with an undergraduate degree in Biomedical Engineering. She currently works as a research Research Assistant at Malizia Clinic where she has compiled Project Briefs and conducted background and market research on new medical devices being developed by the Malizia Clinic. She is also completing a retrospective chart review of Dr. Malizia's patients for analysis and future publication.
 

 

Robert Bozeman

Bob Bozeman's career encompasses three phases including technical development of computer technology (1967-1981), operating roles in development, marketing, sales, and CEO in a variety of computer industry businesses (1982-1997) and advisor, investor, and Board Member (1998 to present).

Bozeman received his degrees in Accounting from the University of Cincinnati (honored with their Distinguished Alumnus Award) and a combined degree in Management and Arts & Sciences from Northeastern University (a member Dean Hopey's Board of Advisors).

In his early career, Bozeman programmed application systems for the retailing industry. From an individual technical contributor, Bozeman progressed into technical and business management.   At Wang Laboratories, Bozeman grew to head their internal systems where they became the largest user of their own products.  Then - as a Vice President working for Dr. Wang - Bozeman started the functions that were necessary to make the company a world-class computer supplier.  This included computer design, quality assurance and diagnostics, applications development and Software Program Products that were sold to the largest accounts in the world.  

Moving to the San Francisco Bay Area, Bozeman developed marketing at Altos Computer Systems and later became the CEO of the combined Acer/Altos Americas organization.

Bozeman partnered with Ron Conway and Casey McGlynn at Angel Investors LP funds I and II as a General Partner.  Noted investments at Angel Investors, LP, included Ask Jeeves, AvantGo, BrightMail, Chemdex/Ventro, FindLaw, Good Technology, Google, MongoMusic, OpenTable, Opsware/LoudCloud, PayPal, RedEnvelope and Vovida Networks.  Involved in the follow-on financing of literally hundreds of these investments, Bozeman was able to work with about 50 of the top venture capital firms in Silicon Valley.

Bozeman is on the Board of Directors of Industrial Origami Holdings, Shakers Vodka, Unify Corporation and partners with Ken Olisa in London-based Restoration Partners.

 

Maureen Carroll

Maureen co-founded Creature in 2003, where she is building a team of designers who understand how to design innovative solutions for consumer, medical, and commercial products. Her strength is her ability to combine analytical skills with creative insights. Creature’s client list includes the Malizia Clinic, MedShape Solutions, Jarden Consumer Solutions, (Sunbeam, Oster, and Healthometer brands), Tupperware, Cooper Lighting, Char-Broil, and the Coca-Cola Company.

Maureen joined Sundberg-Ferar in 1999. As Product Development Manager, she led an integrated team of researchers, designers, and engineers to design successful kitchen appliances, home electronics, medical products, and consumer goods.  

In 1992 Maureen joined Inno, a product development firm in Atlanta, GA. At Inno, Maureen developed medical and consumer products for high-volume manufacture. She designed successful products for the Japanese, Mexican, and European markets, and traveled internationally to conduct market research, evaluate vendors, and coordinate production. In 1997, as Design Manager, she built and led the design team at inno.

Maureen began her career designing medical and industrial equipment at Daedalus Design in Pittsburgh PA.  

Maureen Carroll graduated from Rochester Institute of Technology in 1985 with a BFA in Industrial Design. Her work has been published in ID Magazine, Popular Science, and Time Magazine. She holds numerous design patents, and is an active member of the Industrial Designers Society of America.

 

Julie Turner Collins

Julie Turner Collins is the Director of the Georgia FAST program, which provides assistance to minority/woman-owned and non-metro Atlanta technology businesses applying to the Federal SBIR/STTR program.  This SBA FAST grant awarded to SBIR GA, a service provided by the Advanced Technology Development Center (ATDC) located at Georgia Tech, is designed to enhance the quality of proposals submitted to the Federal SBIR/STTR program from Georgia small technology businesses, as well as provide education to faculty researchers throughout the State.
Prior to becoming Director, Julie worked for 5 years as a Biosciences Startup Catalyst for the Advance Technology Development Center, and was a member of SBIR GA.  SBIR GA was founded in 2005 to provide education and proposal guidance to Georgia entrepreneurs.  Julie worked closely with biotech and life science companies applying for Federal SBIR/STTR awards; specifically NIH grants and contracts.  Her guidance included submission and technical direction as well as proposal review and editing services. In the past five years she assisted more than 150 companies interested in SBIR/STTR funding including direct proposal review of more than 60 Phase I and Phase II submissions.  Julie also assisted Georgia Tech faculty and staff create startup companies from Intellectual Property developed in their academic laboratory. In this capacity she educated faculty on the basic issues surrounding an academic startup opportunity and connected them with appropriate counsel to further advance their technology.

A graduate of Georgia Tech, Julie studied genetic diversity in Haemophilus influenzae at the VA Medical Center in Atlanta prior to obtaining her Thesis Masters degree in Microbiology and Molecular Genetics from Emory University where she studied transcriptional regulation in Streptococcus pyogenes.

 

Richard A. Hillstead, PhD, FAHA

Rick Hillstead is a Partner with Georgia Venture Partners and is responsible for evaluating potential investments and assisting current portfolio medical device companies. Rick has been actively involved in the design and development of medical devices since 1983. Most recently, he was a founding member of The Innovation Factory (TIF) and a principal partner in Accuitive Medical Ventures I and II . At TIF he served as Chief Science Officer and was primarily responsible for technical due diligence and deal structure in areas of Interventional Cardiology and Orthopaedics. He is a past Chairman of Cerebral Vascular Applications, Inc., a current director for Epitek Inc and CEO of Biofisica, Inc.

Prior to TIF, he held several progressive, product research and development positions with Cordis Corporation (Johnson & Johnson) and then directed new technology development for Novoste Corporation. He is an inventor named on more than sixty issued U.S. patents and patent applications and dozens of international patents. His intellectual property has been referenced in over seventeen hundred issued U.S. patents and he has been directly responsible for the development of numerous, commercially successful medical devices.

Dr. Hillstead holds M.B.A. and undergraduate degrees from Nova Southeastern University and a Ph.D. in Business Administration from Southwest University. He is a Fellow of the American Heart Association (FAHA) on the Council of Clinical Cardiology and the council on Nutrition, Physical Activity, and Metabolism.

 

Martin Jacobson

Martin Jacobson has a background in traditional craftsmanship, product development, and product marketing at retail. He graduated with an Industrial Design degree in 2006 from Georgia Tech. He is a design instructor at the Wallace Coulter College of Biomedical Engineering at Georgia Tech, and encourages students to understand their ideas through building them.

 

Patrick J. Kelly, PhD, JD

Dr. Kelly is a partner with Ballard Spahr, LLP in the Intellectual Property Department and a member of the biotechnology practice team in the Patents Group, as well as a member of the Life Sciences/Technology Group. His practice focuses on intellectual property matters related to the life sciences.

Dr. Kelly advises pharmaceutical, biotechnology, and scientific instrumentation companies and venture capitalists. His extensive experience includes working as on-site intellectual property counsel to pharmaceutical and scientific instrumentation companies; conducting validity, due diligence, and freedom-to-operate studies; maintaining a biotech IP estate; and preparing and prosecuting patent applications related to molecular biology. Dr. Kelly also represents clients in several of the biotech incubators in Pennsylvania, as well as academic clients. His background includes knowledge of numerous scientific fields, including biochemistry, immunology, virology, proteomics, genomics, transgenic animals, drug delivery systems, and the preparation of proteins by recombinant DNA methods. Dr. Kelly's experience includes serving as acting director of intellectual property for a major pharmaceutical company, where he was responsible for a wide variety of patent matters, including review of invention disclosures, due diligence studies, freedom-to-operate studies, review of licensing agreements, and related patent matters. He also held the role of on-site patent counsel for the life sciences and chemical analysis division of a leading manufacturer of scientific instruments and analysis equipment.

Dr. Kelly holds degrees from Temple University James E. Beasley School of Law (J.D. 1997, cum laude), Georgia Institute of Technology (Ph.D., molecular biology, 1991), University of Maryland, Baltimore County (M.S., applied molecular biology, 1986), Georgetown University (B.S., biology, 1984).

 

Russell Kroll

As one of Formation Design Group’s founding partners Russell directs industrial & interaction design programs for a broad range of clients. Recently, Russell has lead strategic programs for some of the world’s leading brands including Coca-Cola, Siemens & Xerox, among others. Russell has a specific interest in venture products; start-up companies and the focused development of intellectual property. Russell combines a background in industrial & interaction design with technical understanding to maximize creative & IP opportunities for Formation’s clients.

As a graduate of Chicago’s Institute of Design at the Illinois institute of Technology, Russell started his career as an industrial designer. While working as a designer for corporate & consulting groups in the US & Europe, Russell became increasingly interested in the behavior of products, why things work and feel the way they do and how these characteristics can be manipulated to optimize user experiences. To explore this interest he pursued a MFA in interaction design from one of Europe’s leading deign schools, The Designhögskolan at Sweden’s Umeå University.

Russell’s work has appeared in a variety of international design publications & has been featured on network television in the United States. His work has resulted in numerous patents and multiple domestic & international design awards.

In addition to his role with Formation Design Group, Russell serves as the Product Development Director for Viz Enterprises, an award winning packaging innovation company and is a professional board member at Atlanta’s Museum of Design (MODA).

Russell has a Bachelor of Science in Industrial Design from the Institute of Design at the Illinois Institute of Technology and a Master of Fine Arts in Interaction Design form the Designhögskolan at Sweden’s Umeå University.

 

Mark P. McJunkin

Mark P. McJunkin is Principal at ProductM LLC, an Atlanta industrial design and manufacturing company.

McJunkin is a design instructor in the Wallace Coulter Department of Biomedical Engineering at Georgia Tech. He previously taught for 10 years in the industrial design program in the College or Architecture. McJunkin graduated from Carnegie Mellon in 1994 with BFA with Honors in Industrial Design.

Product M Design (www.productM.com) focuses on CNC manufacturing, parts optimization, and practical domestic lean manufacturing for speed to market and innovation. With proven market success in the athletic, and scientific equipment industry, McJunkin has developed and holds numerous utility and design patents. He has a unique ability to communicate across the many disciplines required to pull together and refine products product concepts and production units. Mark is responsible for blank sheet of paper concept development to short run part production in his Atlanta CNC product development shop. Current customers include LH Thomson Co Inc. and Scimeasure Analytical Systems.
 

 

Alan G. Minsk, JD

Alan Minsk is a Partner and Practice Leader of the Food & Drug Practice Team of Arnall Golden Gregory LLP. Mr. Minsk advises pharmaceutical, medical device and food companies on all legal and regulatory matters relating to the U.S. Food and Drug Administration and the Drug Enforcement Administration.

For companies in the pre-approval phase, Mr. Minsk counsels on clinical trial issues, imports and exports, regulatory strategy including 505(b)(2) new drug applications, orphan drugs, combination products, market exclusivity, premarket notifications, premarket approval applications, communications with FDA, and pre-approval discussions. He also drafts and reviews agreements relating to clinical trials, quality, and contract manufacturing. 

For companies in the commercial phase, he advises on lifecycle management, post-market surveillance, Citizen Petitions, FDA enforcement and inspections, fraud and abuse compliance, promotion and advertising, product liability and interactions with FDA. In addition, works with life science companies and venture capital firms on regulatory diligence matters involving acquisitions, divestitures, co-promotions and licensing. Mr. Minsk conducts in-house training on a wide variety of FDA and fraud and abuse-related topics. He is the General Counsel and a Board member of the PDMA Alliance, Inc., a pharmaceutical trade organization focused on compliance with the Prescription Drug Marketing Act and sample accountability.

  

Raymond W. Pak, MD, PharmD

Dr. Pak is a urologist at the Malizia Clinic.  He specializes in minimally invasive urologic surgery, including robotic, laparoscopic and endourologic techniques.  He is the Director of Robotic Surgery at Piedmont Hospital in Atlanta, Georgia.  He holds a Bachelor of Science degree and a Doctor of Pharmacy from Rutgers College. He received his Medical Degree from The University of Medicine and Dentistry of New Jersey and completed his residency in urology at the Mayo Clinic Graduate School of Medicine in Florida. Dr. Pak then completed the CR BARD minimally invasive oncology and stone fellowship at Thomas Jefferson Medical College in Philadelphia under the guidance of Dr. Demetrius Bagley.

Dr. Pak has authored many peer-reviewed publications in urology journals and textbooks.  He has travelled nationally and internationally to present his research and has won numerous awards.  He has a special interest in the incorporation of advanced technology to treat urologic cancers and stone disease.

 

Stacy Williams Shuker, PhD
Director
Center of Innovation for Life Sciences

Stacy Williams Shuker comes to the Center of Innovation (COI) for Life Sciences with entrepreneurial and research-oriented experience. After graduating from the University of Georgia with a chemistry degree and a doctorate in inorganic chemistry from Carnegie-Mellon, she launched a science toy company and invented a crystal growing kit for children. She received a patent on the kit in 2004 and sold it on children’s websites and via a major retailer. Her experience also includes securing intellectual property rights and navigating the product approval process for retail sale. Prior to coming on board with the Center, she spent two years as a scientific advisor for in an intellectual property law firm. As an inventor who has been on both sides of the patent process, she understands first-hand the conception to commercialization process.
 
After taking leadership of the COI for Life Sciences, Stacy pioneered the use of social media to connect and inform the life science industry. By using tools such as Facebook, Twitter and Ning, she has created a growing network of professionals from scientific, business, legal, regulatory and marketing backgrounds. Stacy is also an active member of GeorgiaBio and is serving as co-chair of the Georgia Life Sciences Summit Poster Session.

 

Douglas Spear, JD
Partner
Nelson Mulliins

Douglas R. Spear practices in Atlanta, where he focuses on the representation of emerging and growth stage technology companies in various sectors, as well as venture capital firms and angel investors.

Mr. Spear works proactively with companies at various stages of their development to solve business and legal problems in a practical and efficient manner.
He also has experience in representing clients in M&A transactions, private placements, and various forms of debt financings. Mr. Spear advises clients on various legal and business matters, including entity formation, corporate governance, capitalization issues, equity compensation strategies, employment matters, capital-raising considerations, customer contracts, and securities law compliance.

Mr. Spear is involved in numerous charitable and civic organizations in Atlanta and previously served on the board of directors of Jewish Family and Career Services.
Mr. Spear has been named a Georgia Rising Star by Super Lawyers in 2009, 2010 and 2011.
In 1998, Mr. Spear earned his Juris Doctor from the University of Pittsburgh. Mr. Spear received his B.A., with honors, in 1995 from the University of Pennsylvania.

 

Brian VanHiel
Principal Engineer
Enginuity Works

Brian VanHiel is a partner in Enginuity Works, an Atlanta area product development company.  Brian’s primary role at Enginuity Works is as chief engineer and manager of medical device projects.
Brian is an expert problem solver and has a knack for boiling any discussion down to its logical foundation.  Experienced in mechanism synthesis and analysis, Brian’s skills help him find solutions that do not sacrifice form for function.

Brian’s experience in medical devices comes from 4 years at Facet Technologies where he was a lead engineer on sensor implantation and lancing devices.  Working within Facet’s design controls, Brian led products from conception through testing and into manufacturing.    Prior to Facet, Brian was a mechanical engineer at Sundberg-Ferar, a product development firm based out of Detroit.  At Sundberg-Ferar, Brian worked side-by-side with industrial designers to create products that were not only beautiful in appearance, but also beautiful functionally.  It is at Sundberg-Ferar that Brian’s expertise in plastics and sheet metal design was honed.

Brian holds a Bachelor and Masters of Science degrees in Mechanical Engineering from Georgia Institute of Technology and is named on seven patent applications and patents.

Sanford B. Weinberg, PhD

Dr. Weinberg is an Associate Professor of Health Care Management (Regulatory Affairs) at Clayton State University. He has over 30 years’ experience at the executive level in multiple pharmaceutical and medical device companies. Past roles included: management consulting at Tunnell Consulting; funding and scientific/technical assistance for 16 university-based start-up companies; providing worldwide regulatory strategy, computer validation, and corporate policy expertise; writing, advising, and providing regulatory support for more than 15 biodefense research grant projects in the past three years; securing licenses for four university-owned biodefense patents; managing FDA NDA, IND, BLA, 510(k) submissions, and PMA applications and the EMEA equivalents; conducting GMP, GLP, GCP, GTP, and Part 11 audits; and training government personnel from the FDA, EMEA, FDA (Korea), Kiro-sho or PMDA (Japan), and ANVISA (Brazil).

Dr. Weinberg is published in numerous peer-reviewed journals and books on biodefense, laboratory automation, quality assurance, regulatory compliance, license applications, and cGMP. He is an internationally recognized expert in regulatory affairs, biodefense, new device and drug development approvals, and clinical research.

 

William L. Warren, JD, MBA

Mr. Warren is a Partner and Chair of the Biotechnology and Life Sciences Team at Sutherland’s Intellectual Property Practice Group. He focuses on patents and licensing for biotechnical, biomedical, pharmaceutical and biomechanical engineering inventions. For almost two decades, he has worked with clients ranging from nonprofit university and research centers to early-stage entrepreneurial companies to multi-national life sciences corporations.

A significant portion of Mr. Warren’s practice includes patent prosecution, counseling clients on patent validity and infringement issues and the preparation of formal product clearance opinions. He also has successfully negotiated technology transfer licensing agreements on behalf of organizations of all sizes. Mr. Warren also protects trademarks and copyrights and, when necessary, litigates intellectual property issues.

Mr. Warren provides leadership to Sutherland’s Biotechnology Patent Team, the majority of whose members also have graduate degrees in the life sciences, and he is Deputy Practice Group Leader for the firm’s Intellectual Property Group. He also serves on the firm’s Hiring Committee and Business Development Committee. Mr. Warren serves as a frequent speaker and author on developments in intellectual property law, particularly those affecting the life sciences industry. Mr. Warren is registered to practice before the U.S. Patent and Trademark Office.

Mr. Warren holds degrees from Emory University School of Law, (1993, Member, Moot Court Society), Georgia State University (1995, M.S., Molecular Genetics), Emory University (1993 MBA), and Middlebury College (1988, B.A., cum laude, Biology and Economics).

 

Jaime Wong, MD, FRCSC

Dr. Wong is a urologist at the Malizia Clinic who specializes in laparoscopic and robotic surgery. He is the Director of Research and Education at the Malizia Clinic and is the Inaugural Urologic Invention Convention Planning Committee Chair.

Dr. Wong holds two Bachelor of Science degrees, a Diploma in Engineering and a Doctor of Medicine degree from Dalhousie University in Halifax, Nova Scotia, Canada. After completing medical school, Dr. Wong pursued postgraduate residency training in Urology at the same facility followed by a Fellowship in Laparoscopy and Endourology at McMaster University in Hamilton, Ontario, Canada.

Dr. Wong is a Fellow of the Royal College of Surgeons of Canada and is active in various organizations including the American Urological Association, the Endourological Society and the Engineering & Urology Society. He has authored numerous peer-reviewed publications and presented his research at national and international scientific meetings. Dr. Wong has also received a number of scholastic accolades and awards, including the prestigious Killam Scholarship.